Anondita Medicare Ltd vs Ep Biocomposites Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Anondita Medicare Ltd is ₹ 706.15 as of 16 Mar 15:30 . The P/E Ratio of Anondita Medicare Ltd is 0 as of March 2025 .The P/E Ratio of EP Biocomposites Ltd is 0 as of March 2025 . The Market Cap of Anondita Medicare Ltd is ₹ 0 crore as of March 2025 .The Market Cap of EP Biocomposites Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Anondita Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of EP Biocomposites Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anondita Medicare Ltd

Anondita Medicare Limited was incorporated as a Public Limited Company on March 12, 2024, with the Registrar of Companies, Central Registration Centre.
Prior to this, Company business was run by current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare (formerly M/s Healthcare Products) from year 1999 onwards. Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand 'COBRA'.
It operate an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated November 21, 2024.
Further, to follow sustainable production practices, Company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh.

About EP Biocomposites Ltd

EP Biocomposites Limited was incorporated as Public Limited Company on January 17, 2020 with the Registrar of Companies, Goa.
Further, pursuant to Business Takeover Agreement dated August 31, 2021, the Company took over the running business of M/s.
OM Ventures, a proprietorship concern through one of its Promoter Leena Kamat.
In September 2022, Company made an Initial Public Offer of 5,04,000 Equity Shares of Rs 10 each by raising funds aggregating to Rs. 6.35 Crore. The Company is involved in manufacturing and supplying of a vast portfolio of products and services, which includes Fibre Glass doors and allied products, Bio Digester Toilets with DRDO technology and actively contributing to wastewater recycling through its solution in Sewage Treatment Plants (STP)and Effluent Treatment Plants (ETP).

FAQs for the comparison of Anondita Medicare Ltd and EP Biocomposites Ltd

Which company has a larger market capitalization, Anondita Medicare Ltd or EP Biocomposites Ltd?

Market cap of Anondita Medicare Ltd is 1,306 Cr while Market cap of EP Biocomposites Ltd is 16 Cr

What are the key factors driving the stock performance of Anondita Medicare Ltd and EP Biocomposites Ltd?

The stock performance of Anondita Medicare Ltd and EP Biocomposites Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anondita Medicare Ltd and EP Biocomposites Ltd?

As of March 16, 2026, the Anondita Medicare Ltd stock price is INR ₹722.1. On the other hand, EP Biocomposites Ltd stock price is INR ₹99.1.

How do dividend payouts of Anondita Medicare Ltd and EP Biocomposites Ltd compare?

To compare the dividend payouts of Anondita Medicare Ltd and EP Biocomposites Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.